DexCom Inc.

$75.36

+$1.62 (2.19%)
Time to buy DXCM?
2 Days. Real Options Skills.

2 Days. Real Options Skills.

Join options trader Ben Sturgill as he reveals his most reliable options strategies - live. Seats are limited.

Save your seat

Trader's Perspective

DXCM bounced from roughly $60 in early May to $75.56 now off strong Q1 results, wider G7 15 Day rollout, and a margin expansion story that got fresh backing at Investor Day.

RANGE
Support: $72Current: $75.56 Target: $85
BEARISH SCENARIO

The stock has the potential to go down if it loses $72, with a retrace toward $68 to $65 in play. Any sign that growth, execution, or quality improvements from management are slipping would speed up that downside.

BULLISH SCENARIO

If DXCM holds the $72 to $73 area, a move back toward $80 to $85 is on the table as traders lean into better margins and steady CGM demand. Resistance near $76 is the first hurdle.

Analysis generated: June 1, 2026 at 12:57 PM ET

Top Gainers

Analyst Ratings

N/A
Average Price Target: $0
Based on 0 analyst ratings in the last 3 months
Sell
0
Hold
0
Buy
0

DexCom Inc. Earnings

We don't currently have information about DexCom Inc.'s earnings.

The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders